Ashtamangal Ventures Llp
About Ashtamangal Ventures Llp
Data last updated: 06 February 2026
Ashtamangal Ventures Llp is a limited liability partnership company based in Sanand, Gujarat, India. It specialises in real estate advisory and brokerage, a part of the broader real estate and construction sector. Incorporated on 16 March 2023.
Registered with ROC Ahmedabad under LLPIN ACA-2491.
Capital: a total obligation of contribution of ₹5 Cr. It is led by designated partners Ruchira Mehul Asnani and Mehul Pratap Asnani.
Office: Sanand, Gujarat.
The LLP is associated with 1 brand - Biotech Healthcare.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered Address1 Abhishree Corporate House, Ambali Road Ambali, Sanand, Gujarat, India – 380058
-
IndustryReal Estate and Construction, Real Estate Services
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Ashtamangal Ventures Llp
Ashtamangal Ventures Llp operates one associated brand: Biotech Healthcare. These brands represent Ashtamangal Ventures Llp's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Develops innovative drugs and devices for ophthalmology, dermatology, orthopedics, and urology. | biotechhealthcare.com |
Competitors & Alternatives of Ashtamangal Ventures Llp
Brands and companies operating in the same space as Ashtamangal Ventures Llp include GE Healthcare, Medtronic, Boston Scientific and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Materials management solutions are provided for healthcare organizations. | Chicago, United States, United States | 1892 |
|
|
Medical equipment for treating over 30 chronic diseases is developed. | Minneapolis, United States, United States | 1949 |
|
|
Wide range of medical devices | Marlborough, United States, United States | 1979 |
|
|
Developer of therapies for the treatment of musculoskeletal disorders | Woburn, United States, United States | 2007 |
|
|
Healthcare solutions are provided by Johnson & Johnson globally. | New Brunswick, United States, United States | 1886 |
|
|
AI-powered drug discovery platform for various diseases | New York, United States, United States | 2016 |
|
|
Surgical instruments are manufactured for multiple therapeutic areas. | Utica, United States, United States | 1987 |
|
|
Complex healthcare challenges are addressed through technology solutions by Commure. | San Francisco, United States, United States | 2016 |
|
|
Adjustable intraocular lens technology is developed using UV-sensitive macromers. | Aliso Viejo, United States, United States | 1997 |
|
|
Biosciences, medication delivery, and renal products are developed and marketed. | Deerfield, United States, United States | 1931 |
Designated Partners of Ashtamangal Ventures Llp
Ashtamangal Ventures Llp is governed by 2 designated partners who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Ruchira Mehul Asnani
Also directs:
Reverie Studio Private Limited, Biotech Vision Care Private Limited, Biotech Lifesciences Private Limited and 1 more
|
Designated Partner | 16 Mar 2023 | 3 Years 3 Months | Current |
|
Mehul Pratap Asnani
Also directs:
Reverie Studio Private Limited, Biotech Vision Care Private Limited, Biotech Lifesciences Private Limited and 1 more
|
Designated Partner | 16 Mar 2023 | 3 Years 3 Months | Current |
Financials of Ashtamangal Ventures Llp
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Charges & Borrowings Ashtamangal Ventures Llp
Ashtamangal Ventures Llp does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ashtamangal Ventures Llp
View historical data on people associated with Ashtamangal Ventures Llp, including employment history and EPFO contributions.
Employee Count & EPFO Data of Ashtamangal Ventures Llp
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Ashtamangal Ventures Llp
GSTIN & GST Filing Data of Ashtamangal Ventures Llp
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Ashtamangal Ventures Llp
Credit Ratings, Legal Cases & Regulatory Alerts of Ashtamangal Ventures Llp
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Ashtamangal Ventures Llp
MSME Payment Delays by Ashtamangal Ventures Llp
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Ashtamangal Ventures Llp
Subsidiaries & Group Companies of Ashtamangal Ventures Llp
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Ashtamangal Ventures Llp with ownership details.
MCA Filings & Documents of Ashtamangal Ventures Llp
MCA Filings & Documents of Ashtamangal Ventures Llp
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Ashtamangal Ventures Llp
Frequently Asked Questions about Ashtamangal Ventures Llp
Ashtamangal Ventures Llp is an active limited liability partnership in the real estate and construction sector based in Sanand, Gujarat, India. It was incorporated on 16 March 2023 (3+ years old) and is registered under LLPIN ACA-2491.
The current designated partners of Ashtamangal Ventures Llp are:
The primary industry of Ashtamangal Ventures Llp is real estate and construction. The LLP specifically operates in real estate services. The LLP is currently active in this sector.
Ashtamangal Ventures Llp can be reached at the registered office: 1 Abhishree Corporate House, Ambali Road Ambali, Sanand, Gujarat, India – 380058.
The total obligation of contribution is ₹5 Cr.
The LLP has its registered office at 1 Abhishree Corporate House, Ambali Road Ambali, Sanand, Gujarat, India – 380058.